Pearly-white patches reminiscent of juvenile morphea

Sara Kerroum, Nadia Ismaili, Mariame Meziane, Laila Benzekri, Karima Senouci

Department of Dermatology, Mohammed V University in Rabat, Ibn Sina University Hospital, Rabat, Morocco

Corresponding Author: Sara Kerroum, MD, E-mail: kerroums1992@gmail.com

How to cite this article: Kerroum S, Ismaili N, Meziane M, Benzekri L, Senouci K. Pearly-white patches reminiscent of juvenile morphea. Our Dermatol Online. 2023;14(1):97.
Submission: 29.05.2022; Acceptance: 27.07.2022
DOI: 10.7241/ourd.20231.22

Citation tools: 

Related Content

Copyright information

© Our Dermatology Online 2023. No commercial re-use. See rights and permissions. Published by Our Dermatology Online.


Morphea is a sclerotic condition limited to the skin corresponding to various clinical entities depending on the extension of the lesions, their linear nature, and their depth [1]. It is a relatively rare condition in children. Although almost never life-threatening, it may in some cases be responsible for functional and/or esthetic disability [2] with a major impact on quality of life, hence the importance of its early diagnosis and treatment. Herein, we report the case of juvenile morphea in plaques.

A ten-year-old child with a history of the first-degree consanguinity of the parents and a family atopic condition presented with four oval, hyperpigmented plaques on the thorax with a pearly-white center (Fig. 1), which were sclerotic on palpation. Dermoscopy revealed an appearance resembling a white cloud (Fig. 2). The rest of the clinical examination was unremarkable. Raynaud’s phenomenon was absent, the genital tract was intact, and no visceral involvement was noted. A skin biopsy was performed confirming the diagnosis of morphea. The child was treated with dermocorticoids with good evolution.

Figure 1: Plaques with a blurred contour and a pearly-white center.
Figure 2: Dermoscopic appearance of a white cloud.

Consent

The examination of the patient was conducted according to the principles of the Declaration of Helsinki. The authors certify that they have obtained all appropriate patient consent forms, in which the patients gave their consent for images and other clinical information to be included in the journal. The patients understand that their names and initials will not be published and due effort will be made to conceal their identity, but that anonymity cannot be guaranteed.

REFERENCES

1. Bono W, Dupin N. [Localized scleroderma (morphea)]. Presse Med. 2006;35:1923-8.

2. Elloudi S, Baybay H, Gallouj S, Mernissi FZ. [Localized scleroderma:About 24 cases]. Pan African Med J. 2017;29:53.

Notes

Source of Support: This article has no funding source,

Conflict of Interest: The authors have no conflict of interest to declare.

Request permissions
If you wish to reuse any or all of this article please use the e-mail (brzezoo77@yahoo.com) to contact with publisher.

Related Content:

Related Articles Search Authors in

Comments are closed.